Typhoid Vi polysaccharide vaccine

Overview

Typhoid Vi polysaccharide vaccine is a vaccine that is administered intramuscularly. It is an active immunization for the prevention of typhoid fever caused by S typhi and is approved for use in persons two years of age or older. The vaccine contains the purified cell surface Vi polysaccharide extracted from Salmonella enterica serovar Typhi, S typhi Ty2 strain. The bacterial culture is inactivated in the medium with the capsular polysaccharides precipated from the solution.

Indication

No indication information available.

Associated Conditions

Typhoid Fever caused by S. typhi

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
Inflammatory Challenge and Fear	2024/10/08	NCT06630884	Phase 1	Recruiting	University of California, San Francisco
Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT	2023/02/27	NCT05745987	Phase 4	Recruiting	McMaster University
Persistent Readiness Through Early Prediction Immunization Study	2022/04/26	NCT05346302	Early Phase 1	Completed	Texas A&M University
Effects of Aging on Primary and Secondary Vaccine Responses	2017/10/18	NCT03312699	Phase 1	Completed	Stanford University

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
Typhim Vi	Sanofi Pasteur Inc.	49281-790	INTRAMUSCULAR	25 ug in 0.5 mL	8/13/2025

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
TYPHIM VI INJECTION 0.025 mg/0.5 ml	SANOFI PASTEUR, SANOFI WINTHROP INDUSTRIE – LE TRAIT	SIN08481P	INJECTION	25 micrograms	12/16/1995

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product	Company	DIN	Dosage Form	Strength	Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product	Company	Registration Number	Pharmaceutical Form	Prescription Type	Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product	Company	Registration Number	Dosage Form	Strength	Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name	MA Holder	MA Number	Pharmaceutical Form	Active Ingredient	Authorization Date
No UK EMC drug information found for this drug.

AI-Powered Research

Premium Access